ofa lawsuit semaglutide Maker of the popular medications Ozempic and Wegovy filed a against Eli Lilly, accusing it of making deceptive advertising claims about its weight-loss drug Zepbound. || FULL STORY IN COMMENTS Ozempic Lawsuit – July 2026

3-5 g/day) are effective for increasing intramuscular creatine stores, muscle accretion and muscle performance/recovery. Its also unnecessary to cycle off creatine because your body wont build up tolerance to it

The NHS says tirzepatide (Mounjaro) and semaglutide (Wegovy) are weight-loss injections that help reduce appetite and slow stomach emptying, and that they should only be prescribed alongside programmes that support healthier eating and physical activity

May AT, Crowe MS, Blakeney BA, Mahavadi S, Wang H, Grider JR, et al

Retatrutide is currently in Phase 3 clinical development

Qsymia comes closest but still falls slightly short of GLP-1 results